25 XP   0   0   10

NanoVibronix Inc
Buy, Hold or Sell?

Let's analyse Nanovibronix together

PenkeI guess you are interested in NanoVibronix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of NanoVibronix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about NanoVibronix Inc

I send you an email if I find something interesting about NanoVibronix Inc.

Quick analysis of Nanovibronix (30 sec.)










What can you expect buying and holding a share of Nanovibronix? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.95
Expected worth in 1 year
$2.82
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$0.87
Return On Investment
116.3%

For what price can you sell your share?

Current Price per Share
$0.75
Expected price per share
$0.7 - $0.81
How sure are you?
50%

1. Valuation of Nanovibronix (5 min.)




Live pricePrice per Share (EOD)

$0.75

Intrinsic Value Per Share

$-18.05 - $10.68

Total Value Per Share

$-16.10 - $12.63

2. Growth of Nanovibronix (5 min.)




Is Nanovibronix growing?

Current yearPrevious yearGrowGrow %
How rich?$3.9m$3.1m$276.7k8.0%

How much money is Nanovibronix making?

Current yearPrevious yearGrowGrow %
Making money-$856.7k-$1.3m$496.5k58.0%
Net Profit Margin-165.5%113.9%--

How much money comes from the company's main activities?

3. Financial Health of Nanovibronix (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#261 / 334

Most Revenue
#266 / 334

Most Profit
#136 / 334

Most Efficient
#262 / 334

What can you expect buying and holding a share of Nanovibronix? (5 min.)

Welcome investor! Nanovibronix's management wants to use your money to grow the business. In return you get a share of Nanovibronix.

What can you expect buying and holding a share of Nanovibronix?

First you should know what it really means to hold a share of Nanovibronix. And how you can make/lose money.

Speculation

The Price per Share of Nanovibronix is $0.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nanovibronix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nanovibronix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.95. Based on the TTM, the Book Value Change Per Share is $0.22 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.50 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nanovibronix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.40-53.0%-0.42-55.8%-0.66-87.8%-0.67-89.9%-0.67-89.0%
Usd Book Value Change Per Share0.000.0%0.2229.1%-0.50-66.9%0.0911.5%0.0912.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.2229.1%-0.50-66.9%0.0911.5%0.0912.6%
Usd Price Per Share0.90-1.86-1.19-1.62-2.61-
Price to Earnings Ratio-0.57--1.08--0.55--1.31--1.61-
Price-to-Total Gains Ratio-2.99--0.46-0.50--6.29-
Price to Book Ratio0.46-1.98-0.99-341.68-170.58-
Price-to-Total Gains Ratio-2.99--0.46-0.50--6.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.75
Number of shares1333
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.220.09
Usd Total Gains Per Share0.220.09
Gains per Quarter (1333 shares)290.69114.81
Gains per Year (1333 shares)1,162.76459.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10116311530459449
20232623160918908
3034883479013781367
4046514642018371826
5058145805022962285
6069776968027552744
7081398131032153203
8093029294036743662
901046510457041334121
1001162811620045924580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.046.00.00.0%
Book Value Change Per Share1.02.01.025.0%5.06.01.041.7%10.09.01.050.0%14.023.03.035.0%14.027.05.030.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.046.00.0%
Total Gains per Share1.02.01.025.0%5.06.01.041.7%10.09.01.050.0%14.023.03.035.0%14.027.05.030.4%

Fundamentals of Nanovibronix

About NanoVibronix Inc

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

Fundamental data was last updated by Penke on 2024-04-11 15:28:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of NanoVibronix Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nanovibronix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Nanovibronix to the Medical Devices industry mean.
  • A Net Profit Margin of -69.1% means that $-0.69 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of NanoVibronix Inc:

  • The MRQ is -69.1%. The company is making a huge loss. -2
  • The TTM is -165.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-69.1%TTM-165.5%+96.5%
TTM-165.5%YOY113.9%-279.5%
TTM-165.5%5Y-438.0%+272.5%
5Y-438.0%10Y-1,099.4%+661.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-69.1%-12.4%-56.7%
TTM-165.5%-20.4%-145.1%
YOY113.9%-14.8%+128.7%
5Y-438.0%-21.3%-416.7%
10Y-1,099.4%-25.0%-1,074.4%
1.1.2. Return on Assets

Shows how efficient Nanovibronix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nanovibronix to the Medical Devices industry mean.
  • -12.2% Return on Assets means that Nanovibronix generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of NanoVibronix Inc:

  • The MRQ is -12.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.2%TTM-15.6%+3.4%
TTM-15.6%YOY-24.0%+8.4%
TTM-15.6%5Y-29.2%+13.6%
5Y-29.2%10Y-53.7%+24.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.2%-4.1%-8.1%
TTM-15.6%-4.7%-10.9%
YOY-24.0%-4.8%-19.2%
5Y-29.2%-4.0%-25.2%
10Y-53.7%-5.2%-48.5%
1.1.3. Return on Equity

Shows how efficient Nanovibronix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nanovibronix to the Medical Devices industry mean.
  • -20.4% Return on Equity means Nanovibronix generated $-0.20 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of NanoVibronix Inc:

  • The MRQ is -20.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -37.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.4%TTM-37.1%+16.7%
TTM-37.1%YOY-43.8%+6.7%
TTM-37.1%5Y-50.5%+13.4%
5Y-50.5%10Y-56.1%+5.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.4%-4.2%-16.2%
TTM-37.1%-5.8%-31.3%
YOY-43.8%-5.7%-38.1%
5Y-50.5%-6.3%-44.2%
10Y-56.1%-7.1%-49.0%

1.2. Operating Efficiency of NanoVibronix Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nanovibronix is operating .

  • Measures how much profit Nanovibronix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nanovibronix to the Medical Devices industry mean.
  • An Operating Margin of -61.7% means the company generated $-0.62  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of NanoVibronix Inc:

  • The MRQ is -61.7%. The company is operating very inefficient. -2
  • The TTM is -101.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-61.7%TTM-101.2%+39.5%
TTM-101.2%YOY-22.4%-78.8%
TTM-101.2%5Y-432.4%+331.2%
5Y-432.4%10Y-1,030.2%+597.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-61.7%-24.3%-37.4%
TTM-101.2%-16.4%-84.8%
YOY-22.4%-13.7%-8.7%
5Y-432.4%-19.9%-412.5%
10Y-1,030.2%-24.5%-1,005.7%
1.2.2. Operating Ratio

Measures how efficient Nanovibronix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.60 means that the operating costs are $1.60 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of NanoVibronix Inc:

  • The MRQ is 1.596. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.615. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.596TTM2.615-1.019
TTM2.615YOY0.109+2.507
TTM2.6155Y5.632-3.017
5Y5.63210Y9.685-4.053
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5961.442+0.154
TTM2.6151.439+1.176
YOY0.1091.431-1.322
5Y5.6321.436+4.196
10Y9.6851.374+8.311

1.3. Liquidity of NanoVibronix Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nanovibronix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.64 means the company has $2.64 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of NanoVibronix Inc:

  • The MRQ is 2.643. The company is able to pay all its short-term debts. +1
  • The TTM is 2.452. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.643TTM2.452+0.191
TTM2.452YOY2.600-0.147
TTM2.4525Y5.892-3.440
5Y5.89210Y4.443+1.449
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6432.726-0.083
TTM2.4522.732-0.280
YOY2.6003.510-0.910
5Y5.8923.617+2.275
10Y4.4433.499+0.944
1.3.2. Quick Ratio

Measures if Nanovibronix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nanovibronix to the Medical Devices industry mean.
  • A Quick Ratio of 1.51 means the company can pay off $1.51 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of NanoVibronix Inc:

  • The MRQ is 1.511. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 0.862. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.511TTM0.862+0.649
TTM0.862YOY1.425-0.563
TTM0.8625Y127.727-126.865
5Y127.72710Y65.280+62.446
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5111.491+0.020
TTM0.8621.633-0.771
YOY1.4252.113-0.688
5Y127.7272.295+125.432
10Y65.2802.255+63.025

1.4. Solvency of NanoVibronix Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nanovibronix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nanovibronix to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.40 means that Nanovibronix assets are financed with 40.2% credit (debt) and the remaining percentage (100% - 40.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of NanoVibronix Inc:

  • The MRQ is 0.402. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.466. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.402TTM0.466-0.063
TTM0.466YOY0.439+0.027
TTM0.4665Y0.407+0.059
5Y0.40710Y1.624-1.217
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4020.389+0.013
TTM0.4660.386+0.080
YOY0.4390.335+0.104
5Y0.4070.442-0.035
10Y1.6240.461+1.163
1.4.2. Debt to Equity Ratio

Measures if Nanovibronix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nanovibronix to the Medical Devices industry mean.
  • A Debt to Equity ratio of 67.4% means that company has $0.67 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of NanoVibronix Inc:

  • The MRQ is 0.674. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.051. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ0.674TTM1.051-0.378
TTM1.051YOY0.809+0.242
TTM1.0515Y0.744+0.308
5Y0.74410Y0.958-0.215
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6740.551+0.123
TTM1.0510.554+0.497
YOY0.8090.479+0.330
5Y0.7440.622+0.122
10Y0.9580.674+0.284

2. Market Valuation of NanoVibronix Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Nanovibronix generates.

  • Above 15 is considered overpriced but always compare Nanovibronix to the Medical Devices industry mean.
  • A PE ratio of -0.57 means the investor is paying $-0.57 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of NanoVibronix Inc:

  • The EOD is -0.472. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.566. Based on the earnings, the company is expensive. -2
  • The TTM is -1.078. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.472MRQ-0.566+0.094
MRQ-0.566TTM-1.078+0.511
TTM-1.078YOY-0.548-0.530
TTM-1.0785Y-1.309+0.231
5Y-1.30910Y-1.605+0.297
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.472-1.077+0.605
MRQ-0.566-1.704+1.138
TTM-1.078-2.081+1.003
YOY-0.548-2.978+2.430
5Y-1.309-2.379+1.070
10Y-1.605-1.726+0.121
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of NanoVibronix Inc:

  • The EOD is -0.781. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.938. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.260. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.781MRQ-0.938+0.156
MRQ-0.938TTM-1.260+0.323
TTM-1.260YOY-0.460-0.801
TTM-1.2605Y-1.361+0.101
5Y-1.36110Y-2.627+1.266
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.781-0.932+0.151
MRQ-0.938-1.578+0.640
TTM-1.260-2.973+1.713
YOY-0.460-6.318+5.858
5Y-1.361-5.307+3.946
10Y-2.627-5.171+2.544
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nanovibronix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.46 means the investor is paying $0.46 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of NanoVibronix Inc:

  • The EOD is 0.385. Based on the equity, the company is cheap. +2
  • The MRQ is 0.462. Based on the equity, the company is cheap. +2
  • The TTM is 1.984. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.385MRQ0.462-0.077
MRQ0.462TTM1.984-1.522
TTM1.984YOY0.989+0.995
TTM1.9845Y341.681-339.697
5Y341.68110Y170.585+171.096
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.3851.876-1.491
MRQ0.4622.372-1.910
TTM1.9842.434-0.450
YOY0.9893.217-2.228
5Y341.6813.893+337.788
10Y170.5854.245+166.340
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of NanoVibronix Inc.

3.1. Institutions holding NanoVibronix Inc

Institutions are holding 16.335% of the shares of NanoVibronix Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Renaissance Technologies Corp2.01330.000141200412000
2023-12-31Vanguard Group Inc1.475503019417786.257
2023-12-31Geode Capital Management, LLC0.706701446100
2023-12-31AmTrust Financial Services Inc0.60630.00771240800
2023-12-31Tower Research Capital LLC0.25710.00015262213768.384
2023-12-31UBS Group AG0.172803537-5331-60.115
2023-12-31BlackRock Inc0.003607400
2023-12-31Wells Fargo & Co0.000601318.3333
2023-12-31Morgan Stanley - Brokerage Accounts0.000501000
2023-12-31Bank of America Corp00100
2023-09-30NewSquare Capital, LLC000-10-100
2023-12-31Armistice Capital, LLC000-29023-100
2023-12-31Virtu Financial LLC000-13783-100
2023-12-31HRT FINANCIAL LLC000-13123-100
Total 5.23640.0079107160-16154-15.1%

3.2. Funds holding NanoVibronix Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.475503019400
2024-02-29Fidelity Extended Market Index0.44910919000
2023-12-31SSgA U.S. Extended Market Index Class I0.1720.0002352000
2024-03-31State St US Extended Mkt Indx NL Cl C0.1720.0002352000
2024-02-29Fidelity Total Market Index0.09540195200
2024-02-29Fidelity Series Total Market Index0.07530154000
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0680139200
2024-02-29Fidelity Nasdaq Composite Index0.06270128400
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.05460111820.1792
2023-12-31SSgA U.S. Total Market Index Strategy0.049601015-23-2.2158
2023-12-31Northern Trust Extended Eq Market Idx0.0466095300
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0466095300
2024-02-29Spartan Total Market Index Pool E0.0242049500
2023-09-30BlackRock Extended Mkt Composite0.003607400
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.002204500
Total 2.79740.000457245-210.0%

3.3. Insider Transactions

Insiders are holding 0.573% of the shares of NanoVibronix Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-06-15Christopher M FashekBUY400000.6
2022-06-01Aurora CassirerBUY20000.69

4. Summary

4.1. Key Performance Indicators

The key performance indicators of NanoVibronix Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.218-100%-0.5020%0.086-100%0.094-100%
Book Value Per Share--1.9491.690+15%1.554+25%1.423+37%0.512+280%
Current Ratio--2.6432.452+8%2.600+2%5.892-55%4.443-41%
Debt To Asset Ratio--0.4020.466-14%0.439-8%0.407-1%1.624-75%
Debt To Equity Ratio--0.6741.051-36%0.809-17%0.744-9%0.958-30%
Dividend Per Share----0%-0%-0%-0%
Eps---0.397-0.419+5%-0.658+66%-0.674+70%-0.668+68%
Free Cash Flow Per Share---0.240-0.353+47%-0.794+231%-0.460+92%-0.349+46%
Free Cash Flow To Equity Per Share---1.973-0.272-86%-0.282-86%-0.052-97%0.155-1377%
Gross Profit Margin--1.2871.190+8%1.170+10%12.706-90%6.942-81%
Intrinsic Value_10Y_max--10.680--------
Intrinsic Value_10Y_min---18.051--------
Intrinsic Value_1Y_max---1.042--------
Intrinsic Value_1Y_min---2.060--------
Intrinsic Value_3Y_max---1.520--------
Intrinsic Value_3Y_min---6.010--------
Intrinsic Value_5Y_max---0.058--------
Intrinsic Value_5Y_min---9.730--------
Market Cap1534762.500-20%1841715.0003811326.875-52%2441295.550-25%6146888.877-70%7168523.613-74%
Net Profit Margin---0.691-1.655+140%1.139-161%-4.380+534%-10.994+1492%
Operating Margin---0.617-1.012+64%-0.224-64%-4.324+601%-10.302+1570%
Operating Ratio--1.5962.615-39%0.109+1371%5.632-72%9.685-84%
Pb Ratio0.385-20%0.4621.984-77%0.989-53%341.681-100%170.585-100%
Pe Ratio-0.472+17%-0.566-1.078+90%-0.548-3%-1.309+131%-1.605+183%
Price Per Share0.750-20%0.9001.863-52%1.193-25%1.623-45%2.609-66%
Price To Free Cash Flow Ratio-0.781+17%-0.938-1.260+34%-0.460-51%-1.361+45%-2.627+180%
Quick Ratio--1.5110.862+75%1.425+6%127.727-99%65.280-98%
Return On Assets---0.122-0.156+28%-0.240+97%-0.292+140%-0.537+341%
Return On Equity---0.204-0.371+82%-0.438+115%-0.505+148%-0.561+175%
Total Gains Per Share---0.218-100%-0.5020%0.086-100%0.094-100%
Usd Book Value--3988000.0003457750.000+15%3181000.000+25%3253919.700+23%1226959.850+225%
Usd Book Value Change Per Share---0.218-100%-0.5020%0.086-100%0.094-100%
Usd Book Value Per Share--1.9491.690+15%1.554+25%1.423+37%0.512+280%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.397-0.419+5%-0.658+66%-0.674+70%-0.668+68%
Usd Free Cash Flow---491000.000-723250.000+47%-1624500.000+231%-923869.650+88%-721859.825+47%
Usd Free Cash Flow Per Share---0.240-0.353+47%-0.794+231%-0.460+92%-0.349+46%
Usd Free Cash Flow To Equity Per Share---1.973-0.272-86%-0.282-86%-0.052-97%0.155-1377%
Usd Market Cap1534762.500-20%1841715.0003811326.875-52%2441295.550-25%6146888.877-70%7168523.613-74%
Usd Price Per Share0.750-20%0.9001.863-52%1.193-25%1.623-45%2.609-66%
Usd Profit---813000.000-856750.000+5%-1353250.000+66%-1391750.217+71%-1150275.108+41%
Usd Revenue--1177000.000776500.000+52%208500.000+465%359981.150+227%208165.575+465%
Usd Total Gains Per Share---0.218-100%-0.5020%0.086-100%0.094-100%
 EOD+2 -5MRQTTM+22 -11YOY+21 -85Y+19 -1410Y+19 -14

4.2. Fundamental Score

Let's check the fundamental score of NanoVibronix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.472
Price to Book Ratio (EOD)Between0-10.385
Net Profit Margin (MRQ)Greater than0-0.691
Operating Margin (MRQ)Greater than0-0.617
Quick Ratio (MRQ)Greater than11.511
Current Ratio (MRQ)Greater than12.643
Debt to Asset Ratio (MRQ)Less than10.402
Debt to Equity Ratio (MRQ)Less than10.674
Return on Equity (MRQ)Greater than0.15-0.204
Return on Assets (MRQ)Greater than0.05-0.122
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of NanoVibronix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.388
Ma 20Greater thanMa 500.821
Ma 50Greater thanMa 1000.923
Ma 100Greater thanMa 2000.963
OpenGreater thanClose0.762
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets6,674
Total Liabilities2,686
Total Stockholder Equity3,988
 As reported
Total Liabilities 2,686
Total Stockholder Equity+ 3,988
Total Assets = 6,674

Assets

Total Assets6,674
Total Current Assets6,487
Long-term Assets187
Total Current Assets
Cash And Cash Equivalents 3,283
Net Receivables 425
Inventory 2,732
Other Current Assets 47
Total Current Assets  (as reported)6,487
Total Current Assets  (calculated)6,487
+/-0
Long-term Assets
Property Plant Equipment 12
Long-term Assets Other 175
Long-term Assets  (as reported)187
Long-term Assets  (calculated)187
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,454
Long-term Liabilities232
Total Stockholder Equity3,988
Total Current Liabilities
Short-term Debt 5
Accounts payable 138
Other Current Liabilities 2,265
Total Current Liabilities  (as reported)2,454
Total Current Liabilities  (calculated)2,408
+/- 46
Long-term Liabilities
Long-term Liabilities  (as reported)232
Long-term Liabilities  (calculated)0
+/- 232
Total Stockholder Equity
Common Stock2
Retained Earnings -66,096
Accumulated Other Comprehensive Income -67
Other Stockholders Equity 70,149
Total Stockholder Equity (as reported)3,988
Total Stockholder Equity (calculated)3,988
+/-0
Other
Cash and Short Term Investments 3,283
Common Stock Shares Outstanding 2,046
Current Deferred Revenue46
Liabilities and Stockholders Equity 6,674
Net Debt -3,278
Net Working Capital 4,033
Short Long Term Debt Total 5



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-30
> Total Assets 
0
349
0
440
435
691
795
0
0
723
3,051
2,629
2,353
1,983
1,651
1,237
924
494
446
757
809
4,865
3,975
3,173
2,425
1,580
1,580
3,107
3,070
2,036
2,036
1,121
4,102
8
8,229
6,832
9,666
8,622
8,622
6,542
5,210
5,879
4,811
3,831
7,361
6,674
6,674
6,6746,6747,3613,8314,8115,8795,2106,5428,6228,6229,6666,8328,22984,1021,1212,0362,0363,0703,1071,5801,5802,4253,1733,9754,8658097574464949241,2371,6511,9832,3532,6293,0517230079569143544003490
   > Total Current Assets 
0
185
0
260
248
224
174
0
0
165
2,858
2,423
2,151
1,776
1,419
988
677
221
159
347
282
4,516
3,621
2,822
2,061
1,226
1,226
2,889
2,847
1,838
1,838
914
3,904
8
7,970
6,584
9,425
8,342
8,342
6,309
4,989
5,609
4,565
3,614
7,168
6,487
6,487
6,4876,4877,1683,6144,5655,6094,9896,3098,3428,3429,4256,5847,97083,9049141,8381,8382,8472,8891,2261,2262,0612,8223,6214,5162823471592216779881,4191,7762,1512,4232,8581650017422424826001850
       Cash And Cash Equivalents 
0
101
0
90
51
94
37
0
0
90
2,796
2,258
1,994
1,614
1,278
799
532
106
51
215
82
4,360
3,491
2,515
1,727
896
896
2,371
2,258
1,338
1,338
93
3,181
7
7,142
5,672
8,599
7,737
7,737
3,944
1,972
2,713
1,512
253
3,787
3,283
3,283
3,2833,2833,7872531,5122,7131,9723,9447,7377,7378,5995,6727,14273,181931,3381,3382,2582,3718968961,7272,5153,4914,36082215511065327991,2781,6141,9942,2582,79690003794519001010
       Net Receivables 
0
24
0
30
125
33
65
0
0
40
33
112
83
41
65
130
82
14
48
50
109
35
52
229
200
144
144
416
485
130
130
360
264
0
93
707
625
264
264
1,437
1,464
109
840
247
32
318
425
425318322478401091,4641,4372642646257079302643601301304854161441442002295235109504814821306541831123340006533125300240
       Other Current Assets 
0
0
0
30
0
32
0
0
0
13
15
98
77
50
54
123
71
34
44
34
80
45
29
70
70
95
42
239
175
268
249
350
350
658
590
36
28
0
166
1,175
1,238
0
782
176
170
0
47
47017017678201,2381,17516602836590658350350249268175239429570702945803444347112354507798151300032030000
   > Long-term Assets 
0
164
0
180
187
467
621
0
0
558
193
206
202
207
232
249
247
273
287
410
527
349
354
351
364
354
354
218
223
198
198
207
198
259
259
248
241
280
280
233
221
270
246
217
193
187
187
1871871932172462702212332802802412482592591982071981982232183543543643513543495274102872732472492322072022061935580062146718718001640
       Property Plant Equipment 
0
28
0
30
24
23
21
0
0
18
16
14
12
10
15
14
12
11
10
8
7
6
6
8
10
8
8
6
5
4
4
3
2
4
35
27
26
54
54
40
36
88
62
44
26
12
12
1212264462883640545426273542344568810866781011121415101214161800212324300280
       Long Term Investments 
0
0
0
0
0
0
0
0
0
182
177
0
0
197
0
0
0
257
272
292
298
338
343
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000034333829829227225700019700177182000000000
       Other Assets 
0
136
0
0
0
444
0
0
0
540
177
192
190
197
217
235
235
262
277
402
520
343
348
343
354
342
359
212
218
194
204
241
0
224
0
221
215
208
224
184
185
179
184
173
0
0
0
000173184179185184224208215221022402412041942182123593423543433483435204022772622352352171971901921775400004440001360
> Total Liabilities 
0
2,181
0
2,860
3,203
3,988
4,540
0
0
6,339
2,822
1,157
1,848
2,192
2,257
2,397
2,527
2,993
3,249
3,808
5,098
1,231
1,021
953
1,039
1,117
1,117
1,172
840
688
688
623
835
6
5,835
2,668
955
2,309
2,309
2,408
2,056
2,646
2,608
2,666
2,671
2,686
2,686
2,6862,6862,6712,6662,6082,6462,0562,4082,3092,3099552,6685,83568356236886888401,1721,1171,1171,0399531,0211,2315,0983,8083,2492,9932,5272,3972,2572,1921,8481,1572,8226,339004,5403,9883,2032,86002,1810
   > Total Current Liabilities 
0
95
0
400
519
3,558
4,024
0
0
5,420
1,934
265
270
297
329
317
403
565
631
754
933
797
583
511
582
640
640
865
522
409
409
352
364
3
2,902
391
266
1,903
1,903
2,053
1,715
2,316
2,289
2,370
2,392
2,454
2,454
2,4542,4542,3922,3702,2892,3161,7152,0531,9031,9032663912,90233643524094095228656406405825115837979337546315654033173292972702651,9345,420004,0243,5585194000950
       Short-term Debt 
0
0
0
0
306
3,107
3,414
0
0
4,617
1,500
1,500
0
0
0
0
0
0
134
713
1,394
0
0
0
0
0
0
0
0
0
0
81
14
0
13
10
10
0
49
33
28
0
55
37
19
0
5
50193755028334901010130148100000000001,3947131340000001,5001,5004,617003,4143,1073060000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
4,617
0
0
0
0
0
0
0
0
134
713
1,394
0
0
0
0
0
0
0
0
0
0
81
14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000148100000000001,394713134000000004,617000000000
       Accounts payable 
0
20
0
50
16
18
33
0
0
101
89
39
39
58
43
28
69
82
123
223
357
168
40
76
143
193
193
343
186
129
129
227
89
632
144
181
62
87
87
173
41
66
45
33
62
138
138
1381386233456641173878762181144632892271291291863431931931437640168357223123826928435839398910100331816500200
       Other Current Liabilities 
0
75
0
350
197
414
577
0
0
618
345
226
231
239
286
289
334
483
508
531
576
629
543
435
439
640
447
522
336
280
280
125
46
2,270
2,546
147
29
1,767
1,723
1,803
1,527
2,169
2,093
2,216
2,238
0
2,265
2,26502,2382,2162,0932,1691,5271,8031,7231,767291472,5462,27046125280280336522447640439435543629576531508483334289286239231226345618005774141973500750
   > Long-term Liabilities 
0
2,086
0
2,460
2,684
430
516
0
0
919
888
892
1,578
1,895
1,928
2,080
2,124
2,428
2,618
3,054
4,165
434
438
442
457
1,117
477
307
318
279
279
271
471
2,933
2,933
2,277
689
406
406
355
341
330
319
296
279
232
232
2322322792963193303413554064066892,2772,9332,9334712712792793183074771,1174574424384344,1653,0542,6182,4282,1242,0801,9281,8951,578892888919005164302,6842,46002,0860
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
134
713
1,394
0
0
0
0
0
86
0
0
0
0
38
28
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000002838000086000001,394713134000000000000000000
       Other Liabilities 
0
140
0
0
0
430
0
0
0
919
888
892
1,578
1,895
1,928
2,080
2,124
2,428
2,484
2,341
2,771
434
438
442
457
477
498
307
318
279
271
505
443
2,915
3,366
2,265
679
406
395
355
341
330
0
296
0
0
0
00029603303413553954066792,2653,3662,9154435052712793183074984774574424384342,7712,3412,4842,4282,1242,0801,9281,8951,5788928889190004300001400
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
358
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,471
2,942
1,848
0
0
0
0
0
0
0
0
0
0
0
000000000001,8482,9422,47100000000000000000000000358000000000
> Total Stockholder Equity
0
-1,832
0
-2,420
-2,768
-3,297
-3,745
0
0
-5,616
229
1,472
505
-209
-606
-1,160
-1,603
-2,499
-2,803
-3,051
-4,289
3,634
2,954
2,220
1,386
463
463
1,935
2,230
1,348
1,348
498
3,267
2,396
2,394
4,164
8,711
6,313
6,313
4,134
3,154
3,233
2,203
1,165
4,690
3,988
3,988
3,9883,9884,6901,1652,2033,2333,1544,1346,3136,3138,7114,1642,3942,3963,2674981,3481,3482,2301,9354634631,3862,2202,9543,634-4,289-3,051-2,803-2,499-1,603-1,160-606-2095051,472229-5,61600-3,745-3,297-2,768-2,4200-1,8320
   Common Stock
0
1
0
0
1
1
0
0
0
0
709
2
2
2
2
2
2
2
2
2
2
4
4
4
4
4
4
4
5
7
5
5
12
22
22
24
27
28
28
28
28
2
2
2
2
0
2
2022222828282827242222125575444444422222222227090000110010
   Retained Earnings Total Equity00000000000-47,788-47,572-42,655-41,650-40,728-39,251-38,3300-36,322-35,215-32,563-31,339-29,995-29,171-28,382-26,741-25,142-24,294-22,576-21,445-20,839-20,229-19,734-18,953-17,914-17,4800000000000
   Accumulated Other Comprehensive Income 
0
-72
0
0
0
-82
0
0
0
-91
-709
0
0
-100
0
0
0
-40
0
-40
0
-45
-45
0
0
-50
-50
0
0
-54
-54
0
0
0
66
59
59
0
60
9
3
0
-25
-55
-54
0
-67
-670-54-55-25039600595966000-54-5400-50-5000-45-450-400-40000-10000-709-91000-82000-720
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
17,706
19,382
19,454
19,521
19,619
19,675
19,838
20,073
21,487
22,087
22,448
32,010
32,119
32,209
32,719
32,993
34,740
38,249
39,358
39,669
39,740
39,935
44,901
44,959
51,832
51,867
0
0
0
0
0
0
0
0
0
0
0
0000000000051,86751,83244,95944,90139,93539,74039,66939,35838,24934,74032,99332,71932,20932,11932,01022,44822,08721,48720,07319,83819,67519,61919,52119,45419,38217,7060000000000
   Treasury Stock00000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
10,453
0
10,860
10,857
10,987
10,961
0
0
11,325
17,706
19,382
19,454
19,621
19,619
19,675
19,838
20,113
21,487
22,087
22,448
32,055
32,119
32,209
32,719
0
33,043
38,249
39,358
0
39,723
39,740
44,901
66
44,959
51,867
63,086
60
63,162
63,468
63,449
-18
65,708
65,774
70,025
0
70,149
70,149070,02565,77465,708-1863,44963,46863,1626063,08651,86744,9596644,90139,74039,723039,35838,24933,043032,71932,20932,11932,05522,44822,08721,48720,11319,83819,67519,61919,62119,45419,38217,70611,3250010,96110,98710,85710,860010,4530



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,283
Cost of Revenue-746
Gross Profit1,5371,537
 
Operating Income (+$)
Gross Profit1,537
Operating Expense-4,973
Operating Income-3,436-3,436
 
Operating Expense (+$)
Research Development185
Selling General Administrative3,924
Selling And Marketing Expenses864
Operating Expense4,9734,973
 
Net Interest Income (+$)
Interest Income0
Interest Expense-135
Other Finance Cost-365
Net Interest Income-500
 
Pretax Income (+$)
Operating Income-3,436
Net Interest Income-500
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,682-3,190
EBIT - interestExpense = -3,571
-3,682
-3,576
Interest Expense135
Earnings Before Interest and Taxes (EBIT)-3,436-3,547
Earnings Before Interest and Taxes (EBITDA)-3,435
 
After tax Income (+$)
Income Before Tax-3,682
Tax Provision-15
Net Income From Continuing Ops-4,957-3,697
Net Income-3,711
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,719
Total Other Income/Expenses Net-246500
 

Technical Analysis of Nanovibronix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nanovibronix. The general trend of Nanovibronix is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nanovibronix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of NanoVibronix Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.81 < 0.81 < 0.81.

The bearish price targets are: 0.725 > 0.7.

Tweet this
NanoVibronix Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of NanoVibronix Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

NanoVibronix Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of NanoVibronix Inc. The current macd is -0.04551512.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Nanovibronix price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Nanovibronix. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Nanovibronix price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
NanoVibronix Inc Daily Moving Average Convergence/Divergence (MACD) ChartNanoVibronix Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of NanoVibronix Inc. The current adx is 19.41.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Nanovibronix shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
NanoVibronix Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of NanoVibronix Inc. The current sar is 0.72065703.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
NanoVibronix Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of NanoVibronix Inc. The current rsi is 39.39. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
NanoVibronix Inc Daily Relative Strength Index (RSI) ChartNanoVibronix Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of NanoVibronix Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Nanovibronix price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
NanoVibronix Inc Daily Stochastic Oscillator ChartNanoVibronix Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of NanoVibronix Inc. The current cci is -77.01186574.

NanoVibronix Inc Daily Commodity Channel Index (CCI) ChartNanoVibronix Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of NanoVibronix Inc. The current cmo is -20.80343379.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
NanoVibronix Inc Daily Chande Momentum Oscillator (CMO) ChartNanoVibronix Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of NanoVibronix Inc. The current willr is -76.74418605.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Nanovibronix is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
NanoVibronix Inc Daily Williams %R ChartNanoVibronix Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of NanoVibronix Inc.

NanoVibronix Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of NanoVibronix Inc. The current atr is 0.06605241.

NanoVibronix Inc Daily Average True Range (ATR) ChartNanoVibronix Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of NanoVibronix Inc. The current obv is 101,097,714.

NanoVibronix Inc Daily On-Balance Volume (OBV) ChartNanoVibronix Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of NanoVibronix Inc. The current mfi is 34.77.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
NanoVibronix Inc Daily Money Flow Index (MFI) ChartNanoVibronix Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for NanoVibronix Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

NanoVibronix Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of NanoVibronix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.388
Ma 20Greater thanMa 500.821
Ma 50Greater thanMa 1000.923
Ma 100Greater thanMa 2000.963
OpenGreater thanClose0.762
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Nanovibronix with someone you think should read this too:
  • Are you bullish or bearish on Nanovibronix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nanovibronix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about NanoVibronix Inc

I send you an email if I find something interesting about NanoVibronix Inc.


Comments

How you think about this?

Leave a comment

Stay informed about NanoVibronix Inc.

Receive notifications about NanoVibronix Inc in your mailbox!